X @Bloomberg
Novo NordiskNovo Nordisk(US:NVO) Bloomberg·2025-08-06 06:00

Financial Performance - Novo Nordisk's second-quarter earnings rose less than expected [1] Market Dynamics - The company is facing competition in the crucial US market for obesity drugs [1]